NDC 0641-6044-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6044
- Requested NDC
- 0641-6044-01
- Package NDCs from labels
- 0641-6044-01, 0641-6044-25
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Injection, USP | REMEDYREPACK INC. | 2024-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam - TYA Pharmaceuticals | TYA Pharmaceuticals | 2011-11-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6044-01 | Lorazepam | 1 mL in 1 VIAL | INJECTION | 1 | 10 | |
| 0641-6044-25 | Lorazepam | 25 in 1 CARTON | INJECTION | 25 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6044-01 | ML - Milliliter | 0641-6044 | 9c10d57c-be4d-4e5c-bd04-680c477d6ef8 | 1 | 2012-07-24 |
| 0641-6044-25 | ML - Milliliter | 0641-6044 | 6e34d5a1-9495-43ce-a1cb-9f6626a83af7 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kroger High Performance Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Kroger | d2aa8963-1922-02f3-e053-2a95a90a7d93 | 2023-12-20 | Warnings | 6DC9Q167V3 B697894SGQ |
| Rite Aid Multi-Symptom Relief Eye Drops | POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | Rite Aid Corporation | efa7d208-9d42-13c7-e053-2a95a90a11b3 | 2023-12-20 | Warnings | B697894SGQ |
| Kroger Eye Drops Advanced Relief | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | Kroger Company | f7ad77fc-d890-25b9-e053-6394a90a2b12 | 2023-12-20 | Warnings | B697894SGQ |
| TopCare Health Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Topco Associates LLC | 9c617e34-fc66-1a5b-e053-2995a90ace2c | 2023-12-20 | Warnings | B697894SGQ |
| Equaline Advanced Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | United Natural Foods, Inc. | f7602789-179a-edfc-e053-6294a90a0844 | 2023-12-20 | Warnings | B697894SGQ |
| Topcare Health Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Topco Assoc LLC | 9c6284f9-00bb-37b5-e053-2a95a90ae2ee | 2023-12-20 | Warnings | 6DC9Q167V3 B697894SGQ |
| HEB Dry Eye Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | HEB | f80023cf-8e42-780a-e053-6294a90a66cd | 2023-12-20 | Warnings | B697894SGQ |
| TopCare Health Advanced Moisturizing Plus Redness Relief | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Topco Associates LLC | 9c6193a6-d822-1b27-e053-2995a90ab3cf | 2023-12-20 | Warnings | B697894SGQ |
| HEB Advanced Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | HEB Grocery Company, LP | f76281d6-3aea-349b-e053-6394a90afca2 | 2023-12-20 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 0ce02d7d-d855-c73f-e063-6294a90abe93 | 2023-12-19 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | db3a6c68-320b-46b0-83fa-6c29297a84a6 | 2023-12-15 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | Alcon Research Ltd | 14916d2c-a63d-491e-bd91-a61f300af38a | 2023-12-15 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane Lubricant | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 15bc06ec-f3dc-3180-ca1a-106769a770ea | 2023-12-15 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane ULTRA | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a5c1c194-3db5-4f18-9cd1-97f7f84c3cff | 2023-12-15 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 7eaa93ca-c843-4c89-921b-c76659410dce | 2023-12-14 | Warnings | 6DC9Q167V3 |
| GenTeal Tears Gel Drops | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 84388a75-9d11-48ce-bf5a-88f0580d2d03 | 2023-12-14 | Warnings | 6DC9Q167V3 B697894SGQ |
| Lorazepam | LORAZEPAM | Leading Pharma, LLC | 5ca13415-4b77-4131-a9d2-6db26bc49167 | 2023-12-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Asclemed USA, Inc. | 91da80c8-3162-43f0-b53e-897070b26a54 | 2023-11-29 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| CVS Maximum Strength LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | CVS Pharmacy Inc. | e6aff579-affb-41bb-8e36-53ea484cb0c5 | 2023-11-26 | Warnings | LKG8494WBH |
| LORAZEPAM | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 247110f2-5468-4593-8d86-41f8c869e03d | 2023-10-17 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.